Klehr N, Schaeg G, Nasemann T
Hautarzt. 1979 Jun;30(6):299-305.
A case of cancer en cuirasse is reported, deriving from a metastasizing malignant mixed tumor of the lacrimal gland. Based on histological criteria, the primary benigne prognosis of mixed tumors of lacrimal glands is discussed. According to sensitivity testing to cytostatic agents treatment with 375 mg of bleomycin achieved a recurrence-free interval of eight months. Pathogenesis of secondary effects are discussed (so-drug-induced called bleomycin-lung).
报告了1例源于泪腺转移性恶性混合瘤的铠甲癌病例。基于组织学标准，讨论了泪腺混合瘤的原发性良性预后。根据细胞抑制剂敏感性测试，使用375毫克博来霉素治疗实现了8个月的无复发间期。讨论了副作用的发病机制（即所谓的药物诱导性博来霉素肺）。
